Acute lymphoblastic leukaemia-type intensive chemotherapy to eliminate minimal residual disease after high-dose melphalan and autologous transplantation in multiple myeloma – a phase I/II feasibility and tolerance study of 17 patients-Reference-Cited by-同舟云学术

Acute lymphoblastic leukaemia-type intensive chemotherapy to eliminate minimal residual disease after high-dose melphalan and autologous transplantation in multiple myeloma – a phase I/II feasibility and tolerance study of 17 patients

Published:2000-04-26 Issue:9 Volume:25 Page:949-956
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Powles R,Sirohi B,Kulkarni S,Bhagwati N,Saso R,Raje N,Horton C,Singhal S,Mehta J,Treleaven J

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/1702379.pdf

Reference42 articles.

1. Raje N, Powles R, Kulkarni S et al. A comparison of vincristine and doxorubicin infusional chemotherapy with methylprednisolone (VAMP) with the addition of weekly cyclophosphamide (C-VAMP) as induction treatment followed by autografting in previously untreated myeloma Br J Haematol 1997 97: 153–160

2. McElwain TJ, Powles RL . High dose intravenous melphalan for plasma cell leukaemia and myeloma Lancet 1983 2: 822–824

3. Cunningham D, Paz-Ares L, Milan S et al. High dose melphalan and autologous bone marrow transplantation as consolidation in previously untreated myeloma J Clin Oncol 1994 12: 759–736

4. Raje N, Powles R, Horton C et al. Comparison of marrow vs blood derived stem cells for autografting in previously untreated multiple myeloma Br J Cancer 1997 75: 1684–1689

5. Attal M, Harousseau JL, Stoppa AM et al. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Francais du Myelome New Engl J Med 1996 335: 91–97

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Minimal Residual Disease Testing in Myeloma Treatment Selection and Drug Development: Current Value and Future Applications;Clinical Cancer Research;2017-04-20

2. Role of MRD status in relation to clinical outcomes in newly diagnosed multiple myeloma patients: a meta-analysis;Bone Marrow Transplantation;2016-09-05

3. High-dose chemotherapy and autologous hematopoietic stem cell transplantation in myeloma patients under the age of 65 years;Bone Marrow Transplantation;2007-08-06

4. Multiple Myeloma;Wiley Handbook of Current and Emerging Drug Therapies;2006-09-15

5. Response to induction chemotherapy is not essential to obtain survival benefit from high-dose melphalan and autotransplantation in myeloma;Bone Marrow Transplantation;2002-11